DrugPatentWatch Database Preview
Neopharma Company Profile
What is the competitive landscape for NEOPHARMA, and when can generic versions of NEOPHARMA drugs launch?
NEOPHARMA has eighteen approved drugs.
There are five US patents protecting NEOPHARMA drugs.
There are ninety-three patent family members on NEOPHARMA drugs in forty-eight countries and seventeen supplementary protection certificates in five countries.
Summary for Neopharma
| International Patents: | 93 |
| US Patents: | 5 |
| Tradenames: | 14 |
| Ingredients: | 7 |
| NDAs: | 18 |
Drugs and US Patents for Neopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neopharma | AUGMENTIN '125' | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 050597-001 | Jul 22, 1985 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Neopharma | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 079049-003 | Aug 4, 2008 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Neopharma | AUGMENTIN ES-600 | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 050755-001 | Jun 22, 2001 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Neopharma | AUGMENTIN '400' | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 050726-002 | May 31, 1996 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for NEOPHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 1000 mg/62.5 mg | ➤ Subscribe | 2009-01-21 |
International Patents for Neopharma Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Uruguay | 26104 | ➤ Try a Free Trial |
| China | 100382782 | ➤ Try a Free Trial |
| Turkey | 200102962 | ➤ Try a Free Trial |
| Norway | 20001870 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Neopharma Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB99/008 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
| 80039 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: IRBESARTAN, DESGEWENST IN DE VORM VAN EEN ZOUT EN/OF EEN HYDRAA T; REGISTRATION NO/DATE: EU/1/97/046/001 - 009 19970827 |
| C0006 | France | ➤ Try a Free Trial | PRODUCT NAME: PIOGLITAZONE/METFORMINE ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/06/354/001 DU 20060728; REGISTRATION NO/DATE AT EEC: EU/1/06/354/001 DU 20060728 |
| 00085 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
